Chest Drainage Catheter Market Size, Share, Industry, Forecast and outlook (2024-2031)

Global Chest Drainage Catheter Market is segmented By Application (Cardiology, Pulmonology, General Intensive Care & Emergency Medicine, Oncology & Pain Management, Infectious Diseases), By End User (Hospitals, Ambulatory Surgery Clinics, and others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031

Chest Drainage Catheter Market Size

The Global Chest Drainage Catheter Market size was valued at US$ 243.47 million in 2022 and is estimated to reach US$ 369.75 million by 2031, growing at a CAGR of 5.5% during the forecast period (2024-2031).

A chest drainage catheter is a tube inserted into the pleural space, the area between the lung and the chest wall, to remove excess fluid or air that can build up and cause difficulty breathing. The tube is typically inserted through the chest wall and is connected to a drainage system that collects the fluid or air and removes it from the body. Chest drainage catheters are commonly used after surgery, trauma, or in conditions such as pneumonia or lung cancer.

Chest Drainage Catheter Market Scope

For More Insights - Request Free Sample

Chest Drainage Catheter Market Dynamics

Technological advancements, the increasing burden of spontaneous pneumothorax across the globe, the rise in the number of thoracic & cardiovascular surgical procedures, and the geriatric population drive the global chest drainage catheter market growth. 

An increasing number of pleural infection patients drive the market growth     

Pleural infection most commonly occurs as a secondary infection in severe or undertreated pneumonia. Still, recently and increasingly, the primary pleural infection has been recognized without evidence of parenchymal infection, possibly due to advances in imaging and earlier computed tomography scanning.

As per the article published in the Journal of Aspiration in 2021, the incidence of the pleural disease is rising and is estimated to be 3000 per million patients in the United Kingdom (UK) alone. The presence of air (pneumothorax) or fluid (pleural effusion) in the pleural space or the development of benign, malignant or infective processes often necessitates intervention to relieve symptoms. Drainage is routinely performed with small bore aspiration kits (usually 6 or 8 French gauge) or insertion of a Seldinger intercostal drain (ICD).

In addition, thoracocentesis and ICD insertion are invasive procedures, and the risk of complications has historically been high. Widespread thoracic ultrasound use has reduced the incidence of complications, including incorrect placement, drain displacement, bleeding, infection, failure to place the drain, pneumothorax, surgical emphysema, re-expansion pulmonary edema and death.

The risk associated with chest drainage catheters will hamper the market's growth

However, chest drainage catheters are generally considered safe, but some risks are associated with their use. Any time a tube is inserted into the body, there is a risk of infection. This risk can be minimized by providing that the insertion site is clean and that proper sterilization procedures are followed. There is a small risk of bleeding at the insertion site or of the catheter causing injury to a blood vessel. One of the risks of a chest drainage catheter is that it may cause a pneumothorax or a collapsed lung. This risk increases if the catheter is inserted improperly or the patient has pre-existing lung conditions. If the catheter becomes dislodged, it can no longer effectively drain the pleural space and may require reinsertion. 

COVID-19 Impact Analysis on Chest Drainage Catheter Market

The COVID-19 pandemic has positively impacted the chest drainage catheter market. The COVID-19 pandemic has significantly impacted the chest drainage catheter market. The increased demand for chest drainage catheters due to the high number of COVID-19 patients requiring treatment for respiratory issues has led to a shortage of these devices in some areas. Additionally, the pandemic has caused disturbances in the supply chain, making it difficult for manufacturers to produce and distribute chest drainage catheters. The market is expected to see significant growth in the coming years as the demand for these devices continues to rise with the ongoing pandemic. 

Chest Drainage Catheter Market Segment Analysis

The pulmonology segment is expected to grow at the fastest CAGR during the forecast period (2023-2030)        

The pulmonology segment accounts for the highest market share. Primary spontaneous pneumothorax (PSP) is the spontaneous occurrence of air in the pleural space in patients without clinically apparent lung disease. The condition is associated with smoking.

As per the article published in BMC Pulmonary Medicine in 2020, recently, the pleural catheter or chest tube was commonly connected to an analog drainage system, in which air leakage is assessed by the observation of bubbling in the water seal. 

In addition, digital drainage systems provide quantitative information on air leakage (flow) in mL/min, both actual and historical, thereby providing information on air leakage patterns. The ability to forecast extended air leakage following pulmonary resection through digital monitoring of air leakage patterns may allow for early intervention.

Chest Drainage Catheter Market Geographical Share

North America region holds the largest market share of the global Chest Drainage Catheter market 

North America dominates the market for chest drainage catheters and is expected to show a similar trend over the forecast period. Technological advancements, the rising prevalence of pulmonary and cardiac disease, and active regional players in the North American region drive the market. 

According to Mayo Clinic, pleural infections remain a prevalent and difficult clinical issue. The incidence of pleural effusions is estimated to be 1.5 million new cases per year in the U.S. above both congestive heart failure and diabetes, which each see 1.8 million new cases each year (400,000 new diagnoses annually). An additional 40,000 people are affected by spontaneous and iatrogenic pneumothoraces.

In addition, ICU Medical offers Pleural Catheter with Flexible Introducer, the one-of-a-kind portex flexible introducer was created to comply with contemporary trauma and emergency treatment approaches for patients with chest injuries, which forbid the use of trocars to place drains. It meets the necessity to establish chest drainage quickly and poses no threat to the patient's internal health. 

Chest Drainage Catheter Market Companies and Competitive Landscape 

The chest drainage catheter market is a moderately competitive presence of local and global companies. Some of the key players which are contributing to the growth of the market are Medtronic, Teleflex Incorporated, Ply Gem Holdings Inc., Smiths Group plc., Medela AG, ATMOS MedizinTechnik GmbH & Co. KG, ARGON MEDICAL, MAQUET Holding B.V. & Co. KG, LivaNova PLC and Cook Medical, among others. The major players are adopting several growth strategies, such as product launches, acquisitions, and collaborations, contributing to the growth of the chest drainage catheter market globally. 

Teleflex Incorporated 

Overview: 

Teleflex is a medical technology company designed to improve the health and quality of people’s lives. The company provides a broad portfolio with solutions in vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. 

Product Portfolio:

Pleur-evac Chest Drainage Systems:  The Pleur-evac Chest Drainage System provides the premier chest drainage solution for thoracic, cardiovascular, trauma, and critical care, which uses the most advanced fluid management technology available.

The global chest drainage catheter market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.